News – Page 581 – Endpoints News

GSK chief Emma Walmsley made $10.8M last year, lagging far behind fellow Big Pharma CEOs

4 years ago

John Maraganore joins up with ProQR as strategic advisor; Servier nabs priority review for Tibsovo sNDA

4 years ago

Looking to push checkpoint efficacy, a quiet microbiome upstart bags $67M for clinical work

4 years ago

Nasal spray maker clinches first PhIII win it needs to reach a much, much bigger market

4 years ago

A lone biotech braves the bone-dry IPO forecast, seeking to go public amidst a barren landscape

4 years ago

Racing Bayer, Astellas puts the final PhIII slide into its FDA/EMA pitch

4 years ago

Gilead draws harsh reviews as PhIII for $21B Immunomedics drug underwhelms Wall Street

4 years ago

A checkpoint 2.0 drug runs into trouble as Alpine gets hit with the latest in a string of clinical holds

4 years ago

Bristol Myers reserves a center spot at Alexandria's big San Diego biotech R&D hub

4 years ago

FDA hands Bristol Myers a landmark approval in early-stage lung cancer after just five days

4 years ago

Pascal Soriot budgets a final £100M to finish AstraZeneca's new HQ — now 9 years and £1B-plus in the making

4 years ago

In passionate appeal, Enamine CEO asks for pharma industry's help to isolate Russia and slow invasion

4 years ago

Bluebird CFO resigns as company faces bleak economic future

4 years ago

The Pfizer papers; Biogen layoffs begin; AbbVie inks a buyout; GSK makes Slaoui pay; and more

4 years ago

Health Canada issues two recalls for Pfizer blood pressure drugs over impurity

4 years ago

Type 2 diabetes drugs and weight loss: Calibrate's model starts with pharma and builds out

4 years ago

Sanofi petitions FDA over 'misleading' label for rival flu vaccine that failed to confirm benefit

4 years ago

'Recall ready': FDA urges companies to comply with drug recall guidance

4 years ago

In new research paper, Novartis outlines how an old SMA program could alter the course of Huntington's

4 years ago

Eli Lilly launches new Verzenio messaging aimed at early-stage breast cancer patients

4 years ago

Former Warp Speed chief agrees to pay GSK back $3.9M following sexual harassment

4 years ago

BeiGene's hematology CMO is on her way out amid market turmoil

4 years ago

With all eyes on Chinese-only oncology data, Coherus and Junshi uncork win for PD-1 drug in esophageal cancer

4 years ago

Exclusive: GV’s first network development partner completes ‘full circle’; Just when Enzyvant scores an ...

4 years ago

First page Previous page 578 579 580581582 583 584 Next page Last page